Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Competition watchdog launches probe into UK vet market

(Sharecast News) - The competition watchdog is to launch a full investigation into the UK's £5bn veterinary market, it was confirmed on Thursday, after an initial review prompted 56,000 responses. The Competition and Markets Authority said the probe will look at whether pet owners are properly informed, if profits are consistent with levels expected in a competitive market and if a limited number of vets in certain areas is impacting customers.

It will also review the sector's regulatory framework.

Sarah Cardell, CMA chief executive, acknowledged "acute" staff shortages in the sector, and accepted that many vets worked in difficult conditions.

But she continued: "The message from our vets work so far has been loud and clear: pet owners and professionals have concerns that need further investigation.

"We have heard from people who are struggling to pay vet bills, potentially overpaying for medicines and don't always know the best treatment options available to them.

"We also remain concerned about the potential impact of sector consolidation and the incentives for large, integrated vet groups to act in ways which reduce consumer choice."

Martin Coleman, group chair of the inquiry, added: "The vet services market is worth an estimated £5bn a year and provides a necessary service to pet owners, so it's right that we fully investigate competition concerns."

Around 16m households in the UK have pets, the CMA noted.

The British Vet Association welcomed the review, telling the BBC that current regulation was "woefully out of date".

As at 0945 BST, shares in retailer and vet group Pets At Home were down 4% at 271p. Shares in veterinary services provider CVS Group were up early 3% at 1,062.9p, however.

Russ Mould, investment direct at AJ Bell, said: "A lot of bad news about a probe into the vet sector has already been priced into the CVS shares, hence the muted reaction to today's update.

"CVS now faces the prospect of an 18-month investigation looming over the business. All it can do is co-operate and get on with the day job."

Share this article

Related Sharecast Articles

Tritax Eurobox says Brookfield offer deadline extended; in talks with other parties
(Sharecast News) - Tritax Eurobox rallied on Tuesday after it said the deadline for Brookfield Asset Management to make an offer for the company has been extended, and that it had received other expressions of interest from a number of parties.
Caspian Sunrise reports progress on several fronts
(Sharecast News) - Caspian Sunrise updated the market on its recent activities on Tuesday, including well testing results, new drilling, and preparations for the charter of the Caspian Explorer.
Tesla shares pop on better-than-expected delivery numbers
(Sharecast News) - Tesla shares were rising on Tuesday, after it reported a smaller-than-expected decline in vehicle deliveries for the second quarter on the back of strategic price cuts and incentives designed to boost demand.
CleanTech announces results of plant location study
(Sharecast News) - CleanTech Lithium announced the results of a plant location study on Tuesday, as part of the ongoing pre-feasibility study (PFS) for its Laguna Verde Project in Chile.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.